Post Your Requirement
Outsourcing of production through Pharma 3rd Party Manufacturing has become a common practice as companies seek to benefit from specialized manufacturing facilities, reduce capital investment and streamline operations. However, with these benefits come the critical responsibility of compliance to the numerous regulatory requirements. Companies must ensure that their third party manufacturers comply with regulatory requirements, provide quality assurance and appropriately manage risks.
In this blog we will outline some of the key compliance guidelines for Third Party Pharmaceutical Manufacturing, helping companies to achieve ethical, legal and operational excellence.
Understanding Pharma 3rd Party Manufacturing
The act of outsourcing pharmaceutical products to a third-party manufacturer is called Pharma 3rd Party Manufacturing or Third Party Manufacturing/3rd Party Pharma.
The client company typically provides the formulation, brand and packaging specifications; however, the manufacturer is responsible for executing the production and its associated testing and sometimes delivers.
The 3rd Party Manufacturing Model is Advantageous to:
- A company that wants to increase the size of its production but does not want to invest in infrastructure to do so.
- A start-up that wants to quickly get to market with pharmaceutical products.
- A company that needs flexibility in its manufacturing to accommodate volume fluctuation.
The 3rd Party Manufacturing Model allows for increased efficiency of operations; however, regulatory compliance obligations will be shared by both the client and the manufacturer.
Key Compliance Guidelines for Pharma 3rd Party Manufacturing
Compliance in Third Party Pharma Manufacturing ensures product safety, efficacy, and regulatory adherence. Here are the essential guidelines:
1. Regulatory Approvals and Licensing
When you enter into a contract with a third-party manufacturer, verify that they possess all necessary licenses from regulatory agencies (such as):
- U.S. FDA (Food and Drug Administration).
- CDSCO (Central Drugs Standard Control Organisation) in India.
- Any other appropriate local regulatory authorities.
This verification indicates that the third-party manufacturer has been granted legal authority to manufacture pharmaceuticals and also adheres to Good Manufacturing Practices (GMP).
2. Good Manufacturing Practices (GMP) Compliance
To maintain compliance with GMP regulations in the manufacturing of pharmaceuticals, both parties involved (the client and manufacturer) must adhere to all relevant hygiene/sanitation standards (facilities). In addition, there are four key components that can help assure compliance: equipment validation/calibration; documentation of processes (to help ensure that processes can be reproduced); and, quality/authenticity verification of raw materials.
Regular audits of facilities performing GMP are essential to remain compliant and avoid regulatory penalties.
3. Quality Assurance and Control
QA is key to the success of any 3rd party manufacturer. The manufacturer must put into place a quality assurance system to ensure their products are safe, effective, and compliant with industry standards. The QA system must include:
1) Batch testing for potency, purity and contaminants in each production run
2) Stability studies to check shelf life of product
3) Documented deviations and corrective actions taken
Client companies should conduct periodic inspections to confirm there is compliance with QA systems.
4. Documentation and Record-Keeping
In the field of Pharmaceutical Third Party Manufacturing, the following are critical documentation principles to follow: Batch and product records, usable evidence, and records of raw material sources and quality certificates. Deviations, complaints, and recall documentation need to be maintained as well.
Proper documentation provides traceability of products and aids in regulatory compliance and inspections.
5. Packaging and Labeling Compliance
Strict packaging and labeling requirements apply to third-party manufacturers such as:
Approved labeling according to appropriate regulations including dosing size, expiration date & ingredient list
- Tamper-resistant packaging
- Batch numbers for traceability
Failing to label according to regulation could result in actions taken by the government or companies, recalls or lawsuits.
6. Risk Management
Identifying & removing risks has a fundamental role at Third Party Pharma Manufacturing. Some of the recommended guidelines for establishing compliance include:
- Before production conduct a risk assessment
- Ensuring all responsibilities are clearly defined in your contractual agreements
- Having contingency plans for supply chain disruptions
By effectively addressing all of these aspects in your risk management plan, both parties (clients and manufacturers) are protected.
7. Ethical Standards and Corporate Responsibility
- Preventing the use of counterfeit or damaged raw products.
- Ensuring your employees are safe while working in manufacturing plants.
- Meeting all the environmental standards and disposing of waste correctly.
Adhering to ethical regulations does not only meet government regulations but can also create credibility for your company’s brand.
8. Contractual and Legal Compliance
When establishing a third party pharmaceutical manufacture:
Clearly define the contract including:
- Scope of contract.
- Responsibilities of each party.
- Quality Expectations of all Parties.
- Include Audits, Confidentiality, Intellectual Property Protection.
- Detailed processes for how future disputes will be settled must be defined.
Contractual obligations create the “legal” framework necessary to properly establish “accountability” for each party in a third party partnership.
9.Training and Capacity Building
Manufacturers need to invest in providing realistic/regular artist training programs to their workforce in order to keep them up to date on good manufacturing practices (GMP’s) and quality standards; ensure they can manage hazardous material properly; and increase efficiency while reducing error and maintaining compliance.
Trained workers will help make manufacturers compliant with regulations and keep the company from incurring unnecessary liabilities and fines through their operational risks.
10. Regular Audits and Continuous Monitoring
Long-term regulation compliance achieved through ongoing monitoring of Third-Party Manufacturing:
Regularly scheduled audits of production sites; adherence to SOPs (Standard Operating Procedures) monitored; Evaluate suppliers on their performance, and what corrective actions, if any, were taken.
A continuous improvement culture ensures sustained quality and regulatory compliance.
Advantages of Compliance in 3rd Party Pharma Manufacturing
Pharmaceutical third-party manufacturing compliance has many advantages.
- Safety in Regulatory Compliance – decreases the chance of receiving fines, recalls and losing your license to operate.
- Quality of Products – ensures that the products produced are consistent, effective and safe.
- Efficiency in Production – provides streamlined production processes, while reducing the legal and operational risks associated with third party manufacturing.
- Trust in Brand – increases the trust that customers and other parties have in a company through compliance.
FAQs
Q1: What is 3rd party manufacturing in the pharmaceutical industry?
A1: 3rd party manufacturing in pharmaceuticals refers to outsourcing the production of pharmaceuticals to a contract manufacturer while retaining ownership of the brand and the associated quality responsibilities.
Q2: Why is compliance important with third-party pharma manufacturers?
A2: Compliance protects both the manufacturer and the client by ensuring the safety of the products produced and protecting the interests of both parties regarding compliance with laws and regulations and managing risk.
Q3: How frequently would audits take place?
A3: Audits should typically be performed on a quarterly or semi-annual basis, depending on the risk profile of the manufacturing facility, as well as the applicable regulatory requirements.
Q4: Can the manufacturer be relied on exclusively to provide quality control?
A4: The manufacturer will provide the day-to-day quality control; however, periodic inspections must be conducted by the client and some level of overall oversight must be maintained.
Q5: Who are the primary regulatory authorities overseeing third-party manufacturing of pharmaceuticals in India?
A5: The regulatory authorities responsible for enforcing compliance with the production of pharmaceuticals produced by third-party manufacturers in India are the Central Drugs Standard Control Organisation (CDSCO) and state licensing authorities. Additionally, good manufacturing practices (GMP) provide the guidelines for operational standards of the facilities.
Conclusion
The benefits of third party manufacturing towards efficiencies and the ability to ramp-up production for pharmaceutical Companies are well known; however, there exists a collective responsibility to provide patients with a safe product, by complying with regulations. As such, the companies that engage in 3rd Party Manufacturing, by complying with regulations, ensuring adherence to GMP, monitoring product quality and maintaining documentation; will achieve Excellence in operations and Improve Patient Safety.
Client companies and manufacturers must work towards aligning their practices with international standards, including the World Health Organization (WHO) standards of Good Manufacturing Practices (GMP). Compliance with WHO standards will lead to safe, consistent products, which will be required to achieve global regulatory acceptance of their product and build Brand credibility by mitigating operational risks.
Investing in compliance provides benefits beyond just regulatory compliance; it is a strategic investment which leads to sustainable growth, building trust in your customers and continuing to operate without risk in a highly competitive pharmaceutical manufacturing environment.
